Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)
NCT00510965
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Choroidal Neovascularization
Interventions
DRUG:
Intravitreal injection ranibizumab
Sponsor
University Hospital, Bonn
Collaborators
[object Object]